Growth Metrics

Travere Therapeutics (TVTX) Revenue Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 64.24%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 7.82%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 19.04%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 3,790.58%
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn 55.63%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 55.63%
Dec 31, 2025 -570.32%
Sep 30, 2025 -36.40%
Jun 30, 2025 111.49%
Mar 31, 2025 97.54%
Dec 31, 2024 65.98%
Sep 30, 2024 69.56%
Jun 30, 2024 68.08%
Mar 31, 2024 33.95%
Dec 31, 2023 53.58%
Sep 30, 2023 32.13%
Jun 30, 2023 12.44%
Mar 31, 2023 31.93%
Dec 31, 2022 118.54%
Sep 30, 2022 -48.95%
Jun 30, 2022 -47.57%
Mar 31, 2022 -50.61%
Dec 31, 2021 -410.38%
Sep 30, 2021 7.55%
Jun 30, 2021 12.78%
Mar 31, 2021 -0.76%
Dec 31, 2020 9.20%
Sep 30, 2020 15.25%
Jun 30, 2020 8.33%
Mar 31, 2020 20.72%
Dec 31, 2019 6.66%
Sep 30, 2019 9.01%
Jun 30, 2019 8.15%
Mar 31, 2019 2.96%
Dec 31, 2018 3.78%
Sep 30, 2018 0.91%
Jun 30, 2018 6.54%
Mar 31, 2018 14.31%
Dec 31, 2017 12.99%
Sep 30, 2017 18.84%
Jun 30, 2017 16.48%
Mar 31, 2017 15.90%
Dec 31, 2016 22.60%
Sep 30, 2016 21.21%
Jun 30, 2016 38.40%
Mar 31, 2016 66.98%
Dec 31, 2015 116.17%
Sep 30, 2015 235.47%
Jun 30, 2015 319.16%
Mar 31, 2015 61,942.86%